-
XtalPi Holdings Limited (HKEX: 2228) (XtalPi) in connection with its HK$1.13 billion (US$145 million) placing of 264 million new shares under general mandate. It is one of the largest share placements in Hong Kong in the last 12 months.
-
ContiOcean Environment Tech Group Co., Ltd. (HKEX: 2613), represented joint sponsors and underwriters in connection with its initial public offering and H share listing on the Main Board of the Hong Kong Stock Exchange. ContiOcean is a PRC-based maritime environmental protection equipment and system provider that aims to help shipowners and other customers in reducing sulfur and GHG emissions and improving maritime operations.
-
InnoScience (Suzhou) Technology Holding Co., Ltd. (InnoScience) (HKEX: 2577), represented joint sponsors and underwriters in connection with its US$180 million initial public offering and H share listing on the Main Board of the Hong Kong Stock Exchange. InnoScience is the first Integrated Device Manufacturer (IDM) in the world that achieved mass production of 8-inch Gallium Nitride on Silicon (GaN-on-Si) wafers and the only company that offers a full voltage spectrum of GaN-on-Si semiconductor products on industrial scale. It houses the world’s largest GaN power semiconductor production base.
-
HK Acquisition Corporation (HKEX: 7841), a publicly traded SPAC in its business combination with Synagistics Pte. Ltd, a data-driven digital commerce solutions platform in Southeast Asia. The successor company has been renamed Synagistics Limited (HKEX: 2562). This is the first de-SPAC transaction and listing in Hong Kong since the SPAC regime under Chapter 18B of the Hong Kong Listing Rules took effect in January 2022.
-
QuantumPharm Inc. (HKEX: 2228) (XtalPi), in connection with its US$126.7 million initial public offering on the Main Board of the Stock Exchange of Hong Kong. This is the first Specialist Technology Company IPO under Chapter 18C of the Listing Rules that came into effect in March 2023, setting a significant milestone for the history of Hong Kong IPOs. XtalPi is also the first artificial intelligence (AI)–powered drug and new material discovery company listed in Hong Kong.
-
Squirrel Enlivened International Co., Ltd., a brand marketing and strategy consulting solutions provider in China, as U.S. counsel in its business combination with Horizon Space Acquisition I Corp. (NASDAQ: HSPO), a publicly traded special purpose acquisition company.
-
Geely Automobile Holdings Limited (HKEX: 175) on the distribution of American Depositary Shares (ADSs) of ZEEKR to Geely Auto’s qualifying shareholders pursuant to Practice Note 15 to the Hong Kong Listing Rules and Regulation S under the U.S. Securities Act, which is in connection with the spin-off listing of ZEEKR Intelligent Technology Holding Limited (NYSE: ZR) on the New York Stock Exchange. ZEEKR raised more than US$440 million in the transaction, making it the largest U.S. IPO of China concept stocks in the past three years.
-
Global Technology Acquisition Corp. I (NASDAQ: GTAC), a publicly traded SPAC, in its US$434 million definitive business combination agreement with Tyfon Culture Holdings Limited, a well-recognized Chinese art trading platform. The combined company will be named Tyfon Culture Inc. (NASDAQ: TFCI).
-
Mobile-health Network Solutions (NASDAQ: MNDR), in connection with its initial public offering and listing of its Class A ordinary shares on the NASDAQ Stock Market LLC. MNDR is a leading telehealth solutions provider in Singapore, which is ranked by the Financial Times #41 of 500 High-Growth Companies Asia-Pacific 2024.
-
Ryde Group Ltd (NYSE American: RYDE), in connection with its initial public offering and listing of its Class A ordinary shares on the NYSE American. Ryde is a technology company with a leading platform for mobility and quick commerce in Singapore, it is the developer of the first carpool app in Singapore.
-
Concord Healthcare Group Co., Ltd. (HKEX: 2453)，represented the joint sponsors and underwriters in connection with its US$ 72.2 million initial public offering and listing of H shares on the Main Board of The Stock Exchange of Hong Kong. Concord Healthcare Group is an oncology healthcare service provider in China.
-
BaTeLab Co., Ltd. (HKEX: 2149) in connection with its initial public offering and H share listing on the Main Board of The Stock Exchange of Hong Kong. BaTeLab is the largest provider of analog IC patterned wafers in China and is also the first IC design company listed in Hong Kong in the last decade.
-
Wuhan YZY Biopharma Co., Ltd. (HKEX: 2496), represented the sole sponsor and underwriters in connection with its US$22.4 million initial public offering and listing of H shares on the Main Board of The Stock Exchange of Hong Kong under Chapter 18A of the Listing Rules. YZY Biopharma is a leading innovation-driven biotechnology company.
-
noco-noco Pte. Ltd., an early stage decarbonization solutions provider focused on technologies to accelerate the global transformation to a carbon-neutral economy, in its business combination with Prime Number Acquisition I Corp. (Nasdaq: PNAC), a publicly traded SPAC. The transaction values noco-noco at US$1.35 billion.
-
A world’s leading crypto miner Bitdeer Technologies Holding Company, representing China Renaissance Securities (Hong Kong) Limited as financial advisor, in its business combination with Blue Safari Group Acquisition Corp., a SPAC listed on Nasdaq (NASDAQ: BSGA). The transaction values Bitdeer at an implied equity value of US$1.18 billion.
-
Ispire Technology Inc. (NASDAQ: ISPR), representing the lead underwriter US Tiger Securities, Inc. as its U.S. counsel in connection with its US$18.9 million initial public offering (IPO) and listing of the common stock on the Nasdaq Capital Market. Ispire is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and other vaping products.
-
TechStar Acquisition Corporation (HKEX: 7855), representing joint sponsors Zero2IPO Capital and China Securities International in connection with its HK$1 billion (US$128.5 million) initial public offering on the Main Board of The Stock Exchange of Hong Kong. TechStar Acquisition Corporation is a SPAC targeting at “new economy” sectors including innovative technology, advanced manufacturing, healthcare, life sciences, culture and entertainment, consumer and new retail, green energy and climate actions industries.
-
LX Technology Group Limited (HKEX: 2436) in its HK$337.2 million (US$43 million) initial public offering and listing on the Main Board of The Stock Exchange of Hong Kong. LX Technology is the largest DaaS provider for SMEs in China and the first company in China to have built DLM (device lifecycle management) business model covering major phases in device lifecycle.
-
Baozun Inc. (HKEX：9991；NASDAQ: BZUN) in connection with the successful voluntary conversion of its secondary listing status to a primary listing status on the Main Board of The Stock Exchange of Hong Kong (HKEX). Baozun, a leader and pioneer in the brand e-commerce service industry in China, has become dual-primary listed on the HKEX and NASDAQ.
-
Yum China Holdings, Inc. (HKEX: 9987; NYSE: YUMC) in connection with the successful voluntary conversion of its secondary listing status to a primary listing status on the Main Board of The Stock Exchange of Hong Kong (HKEX). Yum China, the largest restaurant company in China in terms of system sales, has become dual-primary listed on the HKEX and NYSE.
-
Jianzhi Education Technology Group Co Ltd. (NASDAQ: JZ), representing the underwriter Univest Securities, LLC in connection with its US$25 million initial public offering of American depositary shares on the Nasdaq Global Market. Jianzhi Education is a leading educational content products and IT services provider. It develops educational content for high-quality, professional development training resources in China.
-
HK Acquisition Corporation (HKEX: 7841), a special purpose acquisition company (SPAC) in its HK$1 billion (US$128.2 million) initial offering and listing on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX). This is the third successful SPAC listing in Hong Kong since the SPAC listing rules took effect in January 2022. HK Acquisition Corporation focused on de-SPAC targets in the financial services and technology sectors with competitive edges on sustainability and corporate governance and with operations or prospective operations in the Greater China area.
-
MINISO Group Holding Limited (HKEX: 9896), representing the joint sponsors and underwriters in connection with its HK$567.2 million (US$72.7 million) initial public offering and dual primary listing on the Main Board of The Stock Exchange of Hong Kong Limited. MINISO is the first consumer and retail company to have completed a dual primary listing in Hong Kong, making it one of the highest profile deals in the market in 2022.
-
Mega Genomics Limited (HKEX: 6667) , representing the sole sponsor and underwriters in connection with its HK$215.3 million (US$27.6 million) initial public offering on the Main Board of The Stock Exchange of Hong Kong. Mega Genomics is a leading gene testing platform company in China, with focus on providing consumer-grade gene testing and cancer screening and diagnosis services.
-
Shanghai MicroPort MedBot (Group) Co., Ltd. (HKEX: 2252) in connection with its HK$1.56 billion (US$201 million) initial public offering and listings of H shares on the Main Board The Stock Exchange of Hong Kong. The listing is a spinoff of medical devices manufacturer from MicroPort Scientific Corporation (HKEX:853). Shanghai Microport MedBot is the first HKEX-listed, globally top-tier surgical robot company, dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures.
- Hywin Holdings Ltd. (NASDAQ:HYW) (Hywin) in its US$30 million initial public offering (IPO) on the Nasdaq Global Market. Hywin is the third largest third-party wealth management service provider in China.
- MicroPort CardioFlow Medtech Corporation (HKEX: 2160) in connection with its HK$2.51 billion (US$322 million) initial public offering and listing on the Main Board of the Stock Exchange of Hong Kong. MicroPort CardioFlow is a medical device company in China focusing on research, development, and commercialization of innovative transcatheter and surgical solutions for valvular heart diseases.
- Strawbear Entertainment Group (HKEX: 2125) in connection with its HK$975 million (US$125.74 million) initial public offering on the Main Board of the Stock Exchange of Hong Kong. Represented the joint sponsors and underwriters in the offering. Strawbear is a major drama series producer and distributor in the P.R.C.
- Joy Spreader Interactive Technology. Ltd (HKEX: 6988) in connection with its initial public offering on the Main Board of The Stock Exchange of Hong Kong. The offering raised net proceeds of HK$1.56 billion (approximately US$200 million). Joy Spreader is one of a leading performance-based we-media marketing service providers in China.
- Yum China Holdings, Inc. (HKEX: 9987, NYSE: YUMC) in its HK$17 billion (US$2.2 billion) secondary listing on the Main Board of The Stock Exchange of Hong Kong. Yum China is the largest restaurant company in China with flagship brands including KFC and Pizza Hut, as well as emerging brands such as Little Sheep, Huang Ji Huang, COFFii & JOY, East Dawning, Taco Bell, and Lavazza.
- Kangji Medical Holdings Limited (HKSE: 9997) on its US$404 million (app. HK$3.13 billion) in its initial public offering on the Main Board of The Stock Exchange of Hong Kong as Hong Kong and U.S. legal counsel. Goldman Sachs (Asia) LLC, CLSA Capital Markets Limited and Merrill Lynch Far East Limited acted as joint sponsors for the transaction.
- uCloudLink (NASDAQ: UCL) US$36 million initial public offering and listing on NASDAQ. Represented the underwriters in the offering. uCloudLink is the world's first and leading mobile data traffic sharing marketplace with billions of users around the world.
- AMTD International (NYSE: HKIB; SGX: HKB) US$200 million initial public offering and listing on the New York Stock Exchange. Advised AMTD Global Markets Limited as the lead underwriter. AMTD International is a subsidiary of AMTD Group, comprises the largest independent investment bank in Asia and one of Asia's largest independent asset management companies, and has been a leading investor in FinTech and the new economy sector.
- Jiayin Group Inc., a leading online individual finance marketplace in China, in its US$42 million initial public offering and listing on the NASDAQ Stock Market.
- Shanghai Dongzheng Automotive Finance Co., Ltd., the only auto finance company with a dealership background in China, in its US$208 million H Share global initial public offering and listing on the Hong Kong Stock Exchange. China International Capital Corporation and Credit Suisse as joint sponsors, with China International Capital Corporation, Credit Suisse and Morgan Stanley acted as joint global coordinators, joint bookrunners and joint lead managers of the offering.
- Morgan Stanley, J.P. Morgan Securities, CMBI, CLSA, Credit Suisse, CCBI, ICBCI, ABCI, China Merchants Securities, AMTD and Futu Securities as underwriters in the US$180 million initial public offering and listing on the Hong Kong Stock Exchange of Tongcheng-eLong Holdings Limited, a leading online travel service provider in China.
- Roth Capital Partners and Shenwan Hongyuan Securities as underwriters in the US$49 million initial public offering and listing on the New York Stock Exchange of CNFinance Holdings Limited, a leading home equity loan service provider in China.
- Morgan Stanley, J.P. Morgan, Huatai and UBS, as joint global coordinators and joint bookrunners, in the US$376 million initial public offering and listing on the Hong Kong Stock Exchange of Wise Talent Information Technology Co., Ltd (06100.HK), the largest online talent acquisition services platform in China, which operates Liepin.com.
- Sunlands Online Education Group, a leading online post-secondary and professional education company in China, in its US$149.5 million initial public offering and listing on the New York Stock Exchange.
- Agricultural Bank of China, a leading commercial bank in China with the then-largest domestic distribution network among the large commercial banks in China in terms of the number of branch outlets, in its US$22 billion initial public offering and global offering and concurrent listings on the Hong Kong Stock Exchange and Shanghai Stock Exchange. This was the world’s largest ever IPO at the time of listing.
- China International Capital Corporation Limited, a premier China-based investment bank with international reach, in its US$708 million initial public offering and global offering and listing on the Hong Kong Stock Exchange.
- New China Life Insurance Company Ltd., a leading insurance company in China providing a broad range of life insurance products and services to individual and institutional customers through its extensive distribution network in the country, in its US$1.9 billion initial public offering and global offering and concurrent listings on the Hong Kong Stock Exchange and Shanghai Stock Exchange.
- Yintech Investment Holdings Limited, a leading online provider of spot commodity trading services in China, in its US$101 million initial public offering and listing on NASDAQ.
- CSC Financial Co. Ltd., a leading large full-service investment bank based in China, in its US$915 initial public offering and global offering and listing on the Hong Kong Stock Exchange.
- The underwriters on the proposed U.S. initial public offering and listing on NASDAQ by NetEase Media, Inc., a well-established and leading internet media platform in China.
- Forgame Holdings Limited, a leading developer and publisher of web games in China, in its US$206 million initial public offering and global offering and listing on the Hong Kong Stock Exchange.
- Credit Suisse and UBS as joint book-running managers in the US$76 million initial public offering and listing on the New York Stock Exchange of Zhaopin Limited, a leading on-line career platform in China.
- J.P. Morgan, Credit Suisse, Stifel Nicolaus and Piper Jaffray as the underwriters in the US$116 million initial public offering and listing on NASDAQ by iDreamSky Technology Limited, then the largest independent mobile game publishing platform in China.
- Qunar.com, a leading mobile and online commerce platform for travel in China, in its US$310 million SEC-registered shelf offering of ADSs, including establishment of a WKSI shelf.
- J.P. Morgan as the sole bookrunner in the US$236.3 million Rule 144A and Regulation S global depositary shares offering and listing on the Luxembourg Stock Exchange by TPK Holding Co., Ltd., a leading Taiwan based high-tech touch-screen company.
- Himax Technologies, Inc., one of the world’s leading fabless semiconductor solution providers based in Taiwan, in its US$133 million SEC-registered shelf offering of ADSs by its selling shareholder, including establishment of a non-WKSI shelf.
- Synutra International, Inc., a leading infant formula company in China, on its US$63 million SEC-registered common stock offering.
- Deutsche Bank and Goldman Sachs as joint book-running managers and HSBC as co-manager in the US$88 million SEC-registered shelf offerings of ADSs by Yingli Green Energy Holding, then the world’s largest vertically integrated photovoltaic module supplier based in China.
- UBS and Yuanta as joint lead managers on the US$158 million Rule 144A/Regulation S offering of global depositary shares and listing on the Luxembourg Stock Exchange by WIN Semiconductors Corp., then the world’s largest gallium arsenide semiconductor foundry based in Taiwan, and its selling shareholders.
- A China-based globally leading video monitoring solutions provider in its proposed initial public offering in Hong Kong.
- A China-based specialty pharmaceutical company on its proposed initial public offering in Hong Kong.
- The underwriters on a proposed initial public offering in Hong Kong of a leading China-based fabless semiconductor image sensor company.
- The underwriters on a proposed U.S. initial public offering by a China-based market leader for manufacturing ultra-fast charging and long-life battery power systems for electric vehicles.
- A leading Hong Kong-based medical stent manufacturer on its proposed U.S. initial public offering and listing on NASDAQ.
